Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Clinical overview of the seizure risk of dalfampridine.
SMC Says Yes to Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults with Active Relapsing Remitting-Multiple Sclerosis (RRMS)
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)
Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.
High dose thiamine improves fatigue in multiple sclerosis.
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
A comparative study of experimental mouse models of central nervous system demyelination.
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients (TERI-PRO)
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
Cortical lesion load associates with progression of disability in multiple sclerosis.
High-field imaging of neurodegenerative diseases.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ).
FDA warns about seizures linked to MS drug
Function and distribution of three types of rectifying channel in rat spinal root myelinated axons.

Pages